Clinical Trial Update: Determining the Mechanisms of Loss of CAR T Cell Persistence

View source ↗

Summary

A University College London trial is investigating the mechanisms behind loss of CAR T cell persistence in acute lymphoblastic leukemia and is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• CAR T cell therapy (investigational) (chimeric antigen receptor T cell therapy)

Snippet

Sponsor: University College, London | Conditions: Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia Not Having Achieved Remission | Status: RECRUITING